Mr. Orszag, so much of the discussion today, including some of your discussion with Senator Klobuchar, has focused on the potential harm to customers that consumers might incur from reverse settlements among pharmaceutical manufacturers in this type of context we've been discussing today.
Senator Lee highlights concerns about consumer harm from pharmaceutical settlements.
Share & report
More from Mike Lee
Yes, the Byrd Rule limits what can go in the reconciliation bill, but I’m doing everything I can to support President Trump and move this forward. Stay tuned. We’re just getting started.
Because of the strict constraints of the budget reconciliation process, I was unable to secure clear, enforceable safeguards to guarantee that these lands would be sold only to American families—not to China, not to BlackRock, and not to…
Other voices in this conversation
